409 filings
Page 3 of 21
8-K
e2k4fuo9
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm
8-K
qvk1ld8jgl121jmmhib
31 Mar 23
Departure of Directors or Certain Officers
4:39pm
8-K
cmup78798gctqz h3j1
13 Mar 23
Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange
8:04am
8-K
9pllih8mymqmw
22 Feb 23
Changes in Registrant's Certifying Accountant
6:15pm
8-K
ha8kr1fdgrh
14 Feb 23
Acasti Pharma Reports Third Quarter 2023 Operational Results
7:23am
8-K
f5y7 mr1j
25 Jan 23
Other Events
4:10pm
8-K
hsewg9w bt01
28 Dec 22
Other Events
8:10am
8-K
2z9lh
22 Dec 22
Other Events
8:17am
8-K
5wd7zk8 9p5u8ce1
14 Nov 22
Acasti Pharma Reports Second Quarter 2023 Operational Results
7:15am
8-K
f334qf9f35t ki2ik
30 Sep 22
Acasti Announces Court Dismissal of Stockholder Litigation
4:08pm
8-K
5d5cbaisr5w8xgx
29 Sep 22
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
9:26am
8-K
i4tpf0 z1hh
11 Aug 22
Acasti Pharma Reports First Quarter 2023 Operational Results
7:05am
10-K/A
37eoe6sar
29 Jul 22
Annual report (amended)
5:27pm
8-K
g8xej8z9h 6mv62n
29 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
424B3
tjaxao lj3xqyfjas
23 Jun 22
Prospectus supplement
4:41pm
8-K
ia48t yt51i
21 Jun 22
Results of Operations and Financial Condition
8:10am